Perrigo Company plc reported $4.14B of revenue over the trailing twelve months, −4.2% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $4.14B (to Q2 2026). Net income: −$1.73B, trailing twelve months to Q2 2026. Free cash flow: $119M, trailing twelve months to Q2 2026. Operating margin: −36%, trailing twelve months to Q2 2026.

PRGOPerrigo Company plc

Healthcare

$15.05-26% 1Y

$15.05

$9.0252 weeks$21.46

PRGO as reported

Perrigo Company plc reported $4.14B of revenue over the trailing twelve months, −4.2% on the year before. 11 reported series are charted on this page, each one as filed.

$4.14B

Revenue, trailing twelve months · to Q2 2026 · −4.2% against the twelve months before

Net income: −$1.73B
Net income · +2060% year on year · trailing twelve months to Q2 2026
Free cash flow: $119M
Free cash flow · −54% year on year · trailing twelve months to Q2 2026
Operating margin: −36%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for PRGO, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$4.14B	−4.2%	Q2 2026
Net income	−$1.73B	+2060%	Q2 2026
EPS	−$12.53	+2060%	Q2 2026
Gross margin	33%	n/a	Q2 2026
Operating margin	−36%	n/a	Q2 2026
Net margin	−40%	n/a	Q2 2026
ROE	−48%	n/a	Q2 2026
ROA	−16%	n/a	Q2 2026
ROIC	−14%	n/a	Q2 2026
Free cash flow	$119M	−54%	Q2 2026
P/E	28.7	n/a	Q2 2020 · 24 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.